Traditionally, developing a new drug can take over a decade, but AI technology is changing that timeline. Major pharmaceutical companies like Pfizer and AstraZeneca are leveraging AI to accelerate the ...

Aptiv delivered impressive financial results in the third quarter of 2025, achieving $5.2 billion in revenue, marking a 6% increase. The company also reported $654 million in operating income, up by ...